Related Experiment Videos
Sodium cromoglycate and carbachol-induced bronchoprovocation in asthmatic children
Insights
Sodium cromoglycate (SCG) effectively protects children with mild asthma against carbachol-induced bronchospasm. This study confirms SCG
Area of Science:
- Pediatric Pulmonology
- Pharmacology
- Allergy and Immunology
Background:
- Mild bronchial asthma affects children, necessitating effective treatments.
- Carbachol challenge is a method to assess bronchial hyperresponsiveness.
Purpose of the Study:
- To evaluate the protective effect of sodium cromoglycate (SCG) against carbachol-induced bronchospasm in children with mild asthma.
Main Methods:
- Double-blind, placebo-controlled study involving 10 children with mild asthma.
- Inhaled saline placebo administered on day 1.
- Inhaled placebo or SCG administered on days 2 and 3, 15 minutes before carbachol challenge.
Main Results:
- No significant difference between baseline and placebo values.
- Statistically significant difference observed between baseline and post-SCG values.
- Significant difference noted between placebo and post-SCG values, indicating SCG's protective effect.
Conclusions:
- Sodium cromoglycate (SCG) demonstrates a significant protective effect against carbachol-induced bronchospasm in pediatric mild asthma.
- SCG can be considered a viable option for managing bronchial hyperresponsiveness in this population.
- Further research may explore long-term efficacy and optimal dosing.
Abstract:
Ten children with mild bronchial asthma underwent bronchial challenge with carbachol on three consecutive days; using a double-blind technique, they were given inhaled saline placebo on the first day and placebo or sodium cromoglycate (SCG) on the second and third days 15 min prior to the bronchial provocation test with carbachol. We did not find any significant difference between the baseline and placebo values, but we did obtain a statistically significant difference when comparing baseline with post-SCG and placebo with post-SCG values. These results demonstrate a protective effect of SCG on carbachol-induced bronchospasm in asthmatic children.